Identification and expansion of human lymphokine-activated killer cells: implications for the immunotherapy of cancer.

[1]  G. Goldstein,et al.  Orthoclone OKT3 treatment of acute renal allograft rejection. , 1987, Transplantation proceedings.

[2]  S. Rosenberg,et al.  Human lymphokine-activated killer cells: further isolation and characterization of the precursor and effector cell. , 1987, Natural immunity and cell growth regulation.

[3]  C. Balch,et al.  Lysis of human solid tumor cells by lymphokine-activated natural killer cells. , 1986, Journal of immunology.

[4]  R. Kurzrock,et al.  Clinical toxicity of interferons in cancer patients: a review. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  L. Lanier,et al.  A Map of the Cell Surface Antigens Expressed on Resting and Activated Human Natural Killer Cells , 1986 .

[6]  A. Chang,et al.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. , 1985, The New England journal of medicine.

[7]  T. Kipps,et al.  Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen) , 1985, The Journal of experimental medicine.

[8]  C. Balch,et al.  Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. , 1985, Journal of immunology.

[9]  M. Moore,et al.  A clonal analysis of human peripheral blood lymphocytes displaying natural killer‐like activity , 1985, European journal of immunology.

[10]  J. Werkmeister,et al.  In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells. , 1984, Journal of immunology.

[11]  B. V. van Krimpen,et al.  Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells. , 1984, Journal of immunology.

[12]  G. Trinchieri,et al.  Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. , 1984, Journal of immunology.

[13]  G F Babcock,et al.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. , 1983, Journal of immunology.

[14]  G. Trinchieri,et al.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. , 1983, Journal of immunology.

[15]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells , 1983, The Journal of experimental medicine.

[16]  E. Reinherz,et al.  Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood. , 1982, Journal of immunology.

[17]  S. Rosenberg,et al.  Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. , 1981, Cancer research.

[18]  A. Branellec,et al.  A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. , 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[19]  E. Pick,et al.  Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor. , 1969, Immunology.